Skip to main content
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1999 Sep;81(2):F144–F145. doi: 10.1136/fn.81.2.f144

HFE gene mutation and transferrin saturation in very low birthweight infants

R Maier, H Witt, C Buhrer, E Monch, E Kottgen
PMCID: PMC1720994  PMID: 10448186

Abstract

AIM—To determine if there is an association between high transferrin saturation and the C282Y HFE gene mutation in very low birthweight (VLBW) infants.
METHODS—One hundred and forty three VLBW infants receiving recombinant erythropoietin and 3 to 9 mg/kg/day of enteral iron were studied. Genomic DNA was extracted from filter paper cards. The C282Y mutation was determined by restriction fragment length polymorphism analysis.
RESULTS—Six infants were heterozygous for the mutation; none was homozygous. Ten infants had a transferrin saturation above 80% at least once. No infant was positive for both transferrin saturation above 80% and the mutation.
CONCLUSIONS—The data strongly suggest that there is no association between high transferrin saturation and the HFE gene mutation in VLBW infants during the first weeks of life.



Full Text

The Full Text of this article is available as a PDF (50.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bulaj Z. J., Griffen L. M., Jorde L. B., Edwards C. Q., Kushner J. P. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med. 1996 Dec 12;335(24):1799–1805. doi: 10.1056/NEJM199612123352403. [DOI] [PubMed] [Google Scholar]
  2. Edwards C. Q., Griffen L. M., Goldgar D., Drummond C., Skolnick M. H., Kushner J. P. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988 May 26;318(21):1355–1362. doi: 10.1056/NEJM198805263182103. [DOI] [PubMed] [Google Scholar]
  3. Edwards C. Q., Griffen L. M., Kaplan J., Kushner J. P. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med. 1989 Nov;226(5):373–379. doi: 10.1111/j.1365-2796.1989.tb01411.x. [DOI] [PubMed] [Google Scholar]
  4. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Jr, Ellis M. C., Fullan A. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar]
  5. Maier R. F., Obladen M., Kattner E., Natzschka J., Messer J., Regazzoni B. M., Speer C. P., Fellman V., Grauel E. L., Groneck P. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr. 1998 May;132(5):866–870. doi: 10.1016/s0022-3476(98)70320-8. [DOI] [PubMed] [Google Scholar]
  6. Merryweather-Clarke A. T., Pointon J. J., Shearman J. D., Robson K. J. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997 Apr;34(4):275–278. doi: 10.1136/jmg.34.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES